Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giannis Mountzios

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Annals of Translational Medicine|June 5, 2018
Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)Giannis Mountzios
World Journal of Clinical Oncology|February 11, 2015
Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapyGiannis Mountzios
Annals of Translational Medicine|June 5, 2018
The emerging treatment landscape of advanced non-small cell lung cancerPanagiota Economopoulou, Giannis Mountzios
Annals of Translational Medicine|June 5, 2018
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?Panagiotis Baxevanos, Giannis Mountzios
Expert Review of Clinical Pharmacology|April 27, 2021
Immunotherapy for the treatment of metastatic small cell lung cancer: Focus on pembrolizumabAndreas Koulouris, Giannis Mountzios
Annals of Translational Medicine|June 5, 2018
Beyond <i>EGFR</i> and <i>ALK</i>: targeting rare mutations in advanced non-small cell lung cancerStavros Gkolfinopoulos, Giannis Mountzios
Translational Lung Cancer Research|February 3, 2017
Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapyPanagiota Economopoulou, Giannis Mountzios
Cancers|February 13, 2026
Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future PerspectivesProdromos Koutoukoglou, Giannis Mountzios
Future Oncology (London, England)|February 17, 2016
Novel therapies for advanced squamous cell carcinoma of the lungKonstantinos Koutsoukos, Giannis Mountzios
Immunotherapy|May 4, 2026
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engagerProdromos Koutoukoglou, Giannis Mountzios
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Annals of Translational Medicine|June 5, 2018
Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs)Giannis Mountzios
World Journal of Clinical Oncology|February 11, 2015
Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapyGiannis Mountzios
Annals of Translational Medicine|June 5, 2018
The emerging treatment landscape of advanced non-small cell lung cancerPanagiota Economopoulou, Giannis Mountzios
Annals of Translational Medicine|June 5, 2018
Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?Panagiotis Baxevanos, Giannis Mountzios
Expert Review of Clinical Pharmacology|April 27, 2021
Immunotherapy for the treatment of metastatic small cell lung cancer: Focus on pembrolizumabAndreas Koulouris, Giannis Mountzios
Annals of Translational Medicine|June 5, 2018
Beyond <i>EGFR</i> and <i>ALK</i>: targeting rare mutations in advanced non-small cell lung cancerStavros Gkolfinopoulos, Giannis Mountzios
Translational Lung Cancer Research|February 3, 2017
Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapyPanagiota Economopoulou, Giannis Mountzios
Cancers|February 13, 2026
Neoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future PerspectivesProdromos Koutoukoglou, Giannis Mountzios
Future Oncology (London, England)|February 17, 2016
Novel therapies for advanced squamous cell carcinoma of the lungKonstantinos Koutsoukos, Giannis Mountzios
Immunotherapy|May 4, 2026
Tarlatamab in relapsed small-cell lung cancer: a DLL3-targeted bispecific T-cell engagerProdromos Koutoukoglou, Giannis Mountzios
Pageof 12